An interview with Tamas Masztis
We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.
We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.
We interview Sharon Brownlow, Chief Business Officer at the Cell & Gene Therapy Catapult, which is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry.
An impressive panel brought together expertise in product innovation and development, regulatory affairs and the patient voice to consider these challenges and how to address them.
With 14 interactive panel discussions and opportunities for networking, the event provided a forum to share knowledge, ask questions and gain invaluable industry insights.
With no specific antigens available and a highly immunosuppressive microenvironment with little blood flow, how will researchers tackle solid tumors and bring cell therapy to millions?